652 related articles for article (PubMed ID: 25446182)
1. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
Ong SB; Samangouei P; Kalkhoran SB; Hausenloy DJ
J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
[TBL] [Abstract][Full Text] [Related]
2. Role of the MPTP in conditioning the heart - translatability and mechanism.
Ong SB; Dongworth RK; Cabrera-Fuentes HA; Hausenloy DJ
Br J Pharmacol; 2015 Apr; 172(8):2074-84. PubMed ID: 25393318
[TBL] [Abstract][Full Text] [Related]
3. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury.
Morciano G; Giorgi C; Bonora M; Punzetti S; Pavasini R; Wieckowski MR; Campo G; Pinton P
J Mol Cell Cardiol; 2015 Jan; 78():142-53. PubMed ID: 25172387
[TBL] [Abstract][Full Text] [Related]
4. DJ-1 protects against cell death following acute cardiac ischemia-reperfusion injury.
Dongworth RK; Mukherjee UA; Hall AR; Astin R; Ong SB; Yao Z; Dyson A; Szabadkai G; Davidson SM; Yellon DM; Hausenloy DJ
Cell Death Dis; 2014 Feb; 5(2):e1082. PubMed ID: 24577080
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.
Clarke SJ; Khaliulin I; Das M; Parker JE; Heesom KJ; Halestrap AP
Circ Res; 2008 May; 102(9):1082-90. PubMed ID: 18356542
[TBL] [Abstract][Full Text] [Related]
7. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
[TBL] [Abstract][Full Text] [Related]
8. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ
Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991
[TBL] [Abstract][Full Text] [Related]
9. The RISK pathway leading to mitochondria and cardioprotection: how everything started.
Yellon DM; Beikoghli Kalkhoran S; Davidson SM
Basic Res Cardiol; 2023 May; 118(1):22. PubMed ID: 37233787
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent.
Hausenloy DJ; Boston-Griffiths EA; Yellon DM
Br J Pharmacol; 2012 Mar; 165(5):1235-45. PubMed ID: 21955136
[TBL] [Abstract][Full Text] [Related]
11. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
[TBL] [Abstract][Full Text] [Related]
12. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.
Hausenloy DJ; Ong SB; Yellon DM
Basic Res Cardiol; 2009 Mar; 104(2):189-202. PubMed ID: 19242644
[TBL] [Abstract][Full Text] [Related]
13. Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Li X; Jia P; Huang Z; Liu S; Miao J; Guo Y; Wu N; Jia D
Drug Des Devel Ther; 2019; 13():2331-2342. PubMed ID: 31371925
[TBL] [Abstract][Full Text] [Related]
14. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury.
Bland AR; Payne FM; Ashton JC; Jamialahmadi T; Sahebkar A
Pharmacol Res; 2022 Jan; 175():105986. PubMed ID: 34800627
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.
Boengler K; Hilfiker-Kleiner D; Heusch G; Schulz R
Basic Res Cardiol; 2010 Nov; 105(6):771-85. PubMed ID: 20960209
[TBL] [Abstract][Full Text] [Related]
16. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
Beręsewicz A
Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
[TBL] [Abstract][Full Text] [Related]
17. What makes the mitochondria a killer? Can we condition them to be less destructive?
Murphy E; Steenbergen C
Biochim Biophys Acta; 2011 Jul; 1813(7):1302-8. PubMed ID: 20837069
[TBL] [Abstract][Full Text] [Related]
18. The role of mitochondria in protection of the heart by preconditioning.
Halestrap AP; Clarke SJ; Khaliulin I
Biochim Biophys Acta; 2007 Aug; 1767(8):1007-31. PubMed ID: 17631856
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
